The single-dose vaccine is indicated for active immunization for the prevention of disease caused by chikungunya virus ... that a single dose of the live-attenuated IXCHIQ® vaccine induces ...

The agency approved the company's chikungunya vaccine, Ixchiq, for use in people 18 years ... improve exercise capacity in adult patients who live with moderate or marked limitations of physical ...

The European Commission (EC) has already approved Valneva’s chikungunya vaccine Ixchiq for use in individuals aged 18 years and older, but Bavarian Nordic’s Vimkunya is the first chikungunya vaccine ...

for the world’s first and only chikungunya vaccine, IXCHIQ ®. The single-dose vaccine is indicated for active immunization for the prevention of disease caused by chikungunya virus (CHIKV ...

Valneva's Ixchiq vaccine – which was cleared in the EU, the US, and Canada last year – is currently indicated for preventing chikungunya disease in adults only, although, it is in clinical ...

Paraguayan health authorities Friday confirmed 43 people had died nationwide of chikungunya, while the total number of cases rose to 11,467 over the past three weeks. Eight of the victims were ...

The French pharma company – best known for its COVID-19 jab and recent approval for the world's first chikungunya vaccine Ixchiq – is paying €10 million upfront for a stake in LimmaTech's ...

Robert F. Kennedy Jr. spent the first day of his back-to-back confirmation hearings deftly avoiding questions about his views on vaccines. On the second day, when a prominent Republican senator ...

A groundbreaking study has delivered "exciting" findings, indicating that a new cancer vaccine could be on the verge of becoming a reality. Researchers have disclosed that this innovative jab has ...